Prestige Wealth Management Group LLC Tg Therapeutics, Inc. Transaction History
Prestige Wealth Management Group LLC
- $456 Million
- Q4 2024
A detailed history of Prestige Wealth Management Group LLC transactions in Tg Therapeutics, Inc. stock. As of the latest transaction made, Prestige Wealth Management Group LLC holds 100 shares of TGTX stock, worth $4,133. This represents 0.0% of its overall portfolio holdings.
Number of Shares
100
Previous 100
-0.0%
Holding current value
$4,133
Previous $2,000
50.0%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding TGTX
# of Institutions
372Shares Held
85.6MCall Options Held
3.78MPut Options Held
3M-
Vanguard Group Inc Valley Forge, PA15.6MShares$645 Million0.01% of portfolio
-
Black Rock Inc. New York, NY11.4MShares$471 Million0.0% of portfolio
-
State Street Corp Boston, MA9.2MShares$380 Million0.01% of portfolio
-
Geode Capital Management, LLC Boston, MA3.19MShares$132 Million0.01% of portfolio
-
Pictet Asset Management Holding Sa Carouge, V82.79MShares$115 Million0.09% of portfolio
About TG THERAPEUTICS, INC.
- Ticker TGTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 145,274,000
- Market Cap $6B
- Description
- TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...